Bill
H 1307
Overview: H 1307, "An Act relative to testing for Factor V Leiden", has a hearing scheduled for June 24, 2025, from 10:30 AM to 2:00 PM in the Gardner Auditorium.Purpose and Intent
Overview: H 1307, "An Act relative to testing for Factor V Leiden", has a hearing scheduled for June 24, 2025, from 10:30 AM to 2:00 PM in the Gardner Auditorium.
Purpose and Intent: The bill aims to address the issue of Factor V Leiden, a genetic condition that can increase the risk of blood clots. The legislation seeks to establish requirements and guidelines for testing and screening for this condition.
Key Provisions:
- Mandates that healthcare providers offer testing for Factor V Leiden to certain patient populations, such as those with a family history or at high risk of blood clots
- Requires insurance coverage for Factor V Leiden testing
- Directs the Department of Public Health to develop educational materials and outreach programs related to the condition
Affected Parties and Impacts: The bill would directly impact healthcare providers, insurance companies, and individuals at risk of or diagnosed with Factor V Leiden. It could improve early detection and management of this genetic condition.
Procedural and Timeline Considerations: The bill is currently scheduled for a public hearing on June 24, 2025, where stakeholders and interested parties will have the opportunity to provide input and testimony. The outcome of the hearing will determine the next steps in the legislative process.
Compiled from official sources — confirm details with the bill’s official record.
Sign in to ask a question.
